Evidence map›Paper›PMID 29021386›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Suppression of microRNA Activity in Kidney Collecting Ducts Induces Partial Loss of Epithelial Phenotype and Renal Fibrosis.

Sachin Hajarnis, Matanel Yheskel, Darren Williams, Thomas Brefort, Bob Glaudemans, Huguette Debaix, Michel Baum, Olivier Devuyst, Vishal Patel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Kidney fibrosis: from mechanisms to therapeutic medicines.Signal transduction and targeted therapy · 2023
    Review
  8. MicroRNAs in Mechanical Homeostasis.Cold Spring Harbor perspectives in medicine · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Chronic Kidney Disease: Strategies to Retard Progression.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Kidney inflammaging is promoted by CCR2Cellular and molecular life sciences : CMLS · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sachin HajarnisDivision of Nephrology, Department of Internal Medicine, and.
Matanel YheskelDivision of Nephrology, Department of Internal Medicine, and.
Darren WilliamsDivision of Nephrology, Department of Internal Medicine, and.
Thomas BrefortComprehensive Biomarker Center, Heidelberg, Germany; and.
Bob GlaudemansInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Huguette DebaixInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Michel BaumDivision of Nephrology, Department of Internal Medicine, and.
Olivier DevuystInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Vishal PatelDivision of Nephrology, Department of Internal Medicine, and vishald.patel@utsouthwestern.edu.
University of Zurich · CHThe University of Texas Southwestern Medical Center · USHummingbird Diagnostics (Germany) · DE

Funding

The impact of RNA chemical modifications on polycystic kidney disease progressionR01DK102572 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PATEL, VISHAL · 2015 to 2024
$3.5M
NIDDK NIH HHS R01 DK102572
6 · The paper itself

Abstract

microRNAs (miRNAs) are sequence-specific inhibitors of post-transcriptional gene expression. The physiologic function of these noncoding RNAs in postnatal renal tubules still remains unclear. Surprisingly, they appear to be dispensable for mammalian proximal tubule (PT) function. Here, we examined the effects of miRNA suppression in collecting ducts (CDs). To conclusively evaluate the role of miRNAs, we generated three mouse models with CD-specific inactivation of key miRNA pathway genes

Indexed as

AnimalsArgonaute ProteinsCell LineDEAD-box RNA HelicasesDown-RegulationEpithelial-Mesenchymal TransitionEpitheliumEukaryotic Initiation FactorsFemaleFibrosisGene ExpressionHomeostasisKidney Tubules, CollectingKidney Tubules, ProximalMaleMiceAgo1 protein, mouseAgo2 protein, mouseAgo3 protein, mouseAGO4 protein, mouseArgonaute ProteinsDEAD-box RNA HelicasesDgcr8 protein, mouseDicer1 protein, mouseEukaryotic Initiation FactorsMicroRNAsMirn200 microRNA, mouseRibonuclease IIIRNA-Binding ProteinsSnai1 protein, mouseSnail Family Transcription FactorsZEB1 protein, mouseZEB2 protein, mouseZinc Finger E-box-Binding Homeobox 1Zinc Finger E-box Binding Homeobox 2collecting ductsDicermicroRNAsmiR-200

Identifiers

PMID29021386
PMCPMC5791084
OpenAlexW2763378795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.